FDA Inspection 1194266 — Advancing Sight Network Southwest Regional Office

Advancing Sight Network Southwest Regional Office — FEI 3003562207

The FDA completed an inspection of Advancing Sight Network Southwest Regional Office on December 19, 2022 in Mobile, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 19, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mobile, AL (United States)